Global Enteral Feeding Formulas Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

Description

List of Tables

The global demand for Enteral Feeding Formulas Market is presumed to reach the market size of nearly USD 18.79 BN by 2030 from USD 9.62 BN in 2022 with a CAGR of 7.72% under the study period 2023 - 2030.

Enteral feeding formulas are also known as tube feeding formula considered for medical ailments such as cancer, eating inability, chronic illness, life-threatening injuries, and stroke or attacks. The term enteral feeding describes a procedure in which food is intake through the gastrointestinal tract. The stomach, esophagus, intestines, and mouth constitute the gastrointestinal tract. The nutrition taken via a tube goes directly to the stomach & small intestine. This form of feeding method is used as a supplement. This feeding method enables patients to receive the nutrition that keeps their gastrointestinal tract active.

MARKET DYNAMICS:

The robust growth of the enteral feeding formula market is driven by the increasing prevalence of cancer, dementia, stroke, multiple sclerosis, chronic obstructive pulmonary disease (COPD), liver ailments and other chronic diseases. The rise in preterm births is another major factor augmenting the market growth. The demand for enteral feeding formulas in oncological applications is likely to be fueled by the rising incidence of cancer, the transition from hospitals to outpatient care settings, and the growing acceptance of enteral feeding formulas as an efficient substitute for parenteral nutrition among cancer patients.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of enteral feeding formulas. The growth and trends of enteral feeding formulas industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the enteral feeding formulas market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Standard Formula
Disease-Specific Formula

By Flow Type

Intermittent Feeding Flow
Continuous Feeding Flow

By Stage

Adult
Pediatric

By Indication

Alzheimer'S
Nutrition Deficiency
Cancer Care
Diabetes
Chronic Kidney Diseases
Orphan Diseases
Dysphagia
Pain Management
Malabsorption/GI Disorder/Diarrhea
Others

By End-User

Hospitals (Cardiology, Neurology, Critical Care (ICU), Oncology, Others)
Home Care

By Sales Channel

Online Sales
Institutional Sales
Retail Sales

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Enteral Feeding Formulas market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the enteral feeding formulas market include Abbott, Danone SA, Fresenius Kabi, Nestle, Victus, Inc., Primus Pharmaceuticals, Inc., Meiji Holdings. Co., Ltd and Rickett Benckiser Group Plc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11219148

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . ENTERAL FEEDING FORMULAS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Flow Type
- 3.7.3 Market Attractiveness Analysis By Stage
- 3.7.4 Market Attractiveness Analysis By Indication
- 3.7.5 Market Attractiveness Analysis By End-user
- 3.7.6 Market Attractiveness Analysis By Sales Channel
- 3.7.7 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY PRODUCT

6.1 Overview by Product
6.2 Historical and Forecast Data
6.3 Analysis by Product
6.4 Standard Formula Historic and Forecast Sales by Regions
6.5 Disease-specific Formula Historic and Forecast Sales by Regions

7 . GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY FLOW TYPE

7.1 Overview by Flow Type
7.2 Historical and Forecast Data
7.3 Analysis by Flow Type
7.4 Intermittent Feeding Flow Historic and Forecast Sales by Regions
7.5 Continuous Feeding Flow Historic and Forecast Sales by Regions

8 . GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY STAGE

8.1 Overview by Stage
8.2 Historical and Forecast Data
8.3 Analysis by Stage
8.4 Adult Historic and Forecast Sales by Regions
8.5 Pediatric Historic and Forecast Sales by Regions

9 . GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY INDICATION

9.1 Overview by Indication
9.2 Historical and Forecast Data
9.3 Analysis by Indication
9.4 Alzheimer's Historic and Forecast Sales by Regions
9.5 Nutrition Deficiency Historic and Forecast Sales by Regions
9.6 Cancer Care Historic and Forecast Sales by Regions
9.7 Diabetes Historic and Forecast Sales by Regions
9.8 Chronic Kidney Diseases Historic and Forecast Sales by Regions
9.9 Orphan Diseases Historic and Forecast Sales by Regions
9.10. Dysphagia Historic and Forecast Sales by Regions
9.11 Pain Management Historic and Forecast Sales by Regions
9.12 Malabsorption/GI Disorder/Diarrhea Historic and Forecast Sales by Regions
9.13 Others Historic and Forecast Sales by Regions

10 . GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY END-USER

10.1 Overview by End-user
10.2 Historical and Forecast Data
10.3 Analysis by End-user
10.4 Hospitals (Cardiology, Neurology, Critical Care (ICU), Oncology, Others) Historic and Forecast Sales by Regions
10.5 Home Care Historic and Forecast Sales by Regions

11 . GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY SALES CHANNEL

11.1 Overview by Sales Channel
11.2 Historical and Forecast Data
11.3 Analysis by Sales Channel
11.4 Online Sales Historic and Forecast Sales by Regions
11.5 Institutional Sales Historic and Forecast Sales by Regions
11.6 Retail Sales Historic and Forecast Sales by Regions

12 . GLOBAL ENTERAL FEEDING FORMULAS MARKET SALES ANALYSIS BY GEOGRAPHY

12.1. Regional Outlook
12.2. Introduction
12.3. North America Sales Analysis
- 12.3.1. Overview, Historic and Forecast Sales Analysis
- 12.3.2. North America By Segment Sales Analysis
- 12.3.3. North America By Country Sales Analysis
- 12.3.4. United State Sales Analysis
- 12.3.5. Canada Sales Analysis
- 12.3.6. Mexico Sales Analysis
12.4. Europe Sales Analysis
- 12.4.1. Overview, Historic and Forecast Sales Analysis
- 12.4.2. Europe by Segment Sales Analysis
- 12.4.3. Europe by Country Sales Analysis
- 12.4.4. United Kingdom Sales Analysis
- 12.4.5. France Sales Analysis
- 12.4.6. Germany Sales Analysis
- 12.4.7. Italy Sales Analysis
- 12.4.8. Russia Sales Analysis
- 12.4.9. Rest Of Europe Sales Analysis
12.5. Asia Pacific Sales Analysis
- 12.5.1. Overview, Historic and Forecast Sales Analysis
- 12.5.2. Asia Pacific by Segment Sales Analysis
- 12.5.3. Asia Pacific by Country Sales Analysis
- 12.5.4. China Sales Analysis
- 12.5.5. India Sales Analysis
- 12.5.6. Japan Sales Analysis
- 12.5.7. South Korea Sales Analysis
- 12.5.8. Australia Sales Analysis
- 12.5.9. Rest Of Asia Pacific Sales Analysis
12.6. Latin America Sales Analysis
- 12.6.1. Overview, Historic and Forecast Sales Analysis
- 12.6.2. Latin America by Segment Sales Analysis
- 12.6.3. Latin America by Country Sales Analysis
- 12.6.4. Brazil Sales Analysis
- 12.6.5. Argentina Sales Analysis
- 12.6.6. Peru Sales Analysis
- 12.6.7. Chile Sales Analysis
- 12.6.8. Rest of Latin America Sales Analysis
12.7. Middle East & Africa Sales Analysis
- 12.7.1. Overview, Historic and Forecast Sales Analysis
- 12.7.2. Middle East & Africa by Segment Sales Analysis
- 12.7.3. Middle East & Africa by Country Sales Analysis
- 12.7.4. Saudi Arabia Sales Analysis
- 12.7.5. UAE Sales Analysis
- 12.7.6. Israel Sales Analysis
- 12.7.7. South Africa Sales Analysis
- 12.7.8. Rest Of Middle East And Africa Sales Analysis

13 . COMPETITIVE LANDSCAPE OF THE ENTERAL FEEDING FORMULAS COMPANIES

13.1. Enteral Feeding Formulas Market Competition
13.2. Partnership/Collaboration/Agreement
13.3. Merger And Acquisitions
13.4. New Product Launch
13.5. Other Developments

14 . COMPANY PROFILES OF ENTERAL FEEDING FORMULAS INDUSTRY

14.1. Top Company Share Analysis
14.2. Market Concentration Rate
14.3. Abbott
- 14.3.1. Company Overview
- 14.3.2. Company Revenue
- 14.3.3. Products
- 14.3.4. Recent Developments
14.4. Danone SA
- 14.4.1. Company Overview
- 14.4.2. Company Revenue
- 14.4.3. Products
- 14.4.4. Recent Developments
14.5. Fresenius Kabi
- 14.5.1. Company Overview
- 14.5.2. Company Revenue
- 14.5.3. Products
- 14.5.4. Recent Developments
14.6. Nestle
- 14.6.1. Company Overview
- 14.6.2. Company Revenue
- 14.6.3. Products
- 14.6.4. Recent Developments
14.7. Victus Inc.
- 14.7.1. Company Overview
- 14.7.2. Company Revenue
- 14.7.3. Products
- 14.7.4. Recent Developments
14.8. Primus Pharmaceuticals Inc.
- 14.8.1. Company Overview
- 14.8.2. Company Revenue
- 14.8.3. Products
- 14.8.4. Recent Developments
14.9. Meiji Holdings. Co. Ltd
- 14.9.1. Company Overview
- 14.9.2. Company Revenue
- 14.9.3. Products
- 14.9.4. Recent Developments
14.10. Rickett Benckiser Group Plc.
- 14.10.1. Company Overview
- 14.10.2. Company Revenue
- 14.10.3. Products
- 14.10.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies